Currently, endoscopy with biopsy remains the primary method to determine inflammatory activity in eosinophilic esophagitis (EoE). During various treatment protocols, patients routinely undergo several endoscopic examinations. Endoscopy is not only an invasive procedure but one that requires financial, emotional and time costs for patients with EoE. This non-invasive, non-endoscopic method should replace the need for repeated endoscopies in EoE, thereby offering a safer and most cost-effective management strategy for EoE. The proposal will determine the potential advantages of the Esophageal Inflammation Monitor (EIM) to determine its potential clinical application.
|Effective start/end date||8/15/13 → 5/31/20|
- University of Illinois at Chicago (7046-06//5R01FD004086-04)
- Food and Drug Administration (7046-06//5R01FD004086-04)